MS

Madhu Singh

Active Director Director DIN 06404993
DIN 06404993 First appointment Oct 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2012
Shareholding value •••• Premium profile

About Madhu Singh

Data last updated:

Madhu Singh is a Director at Kiran Pharmaceuticals Private Limited (since 2012). The company operates in Trading. Kiran Pharmaceuticals Private Limited reported revenue of ₹11.4 Lakh (FY 2024).

DIN 06404993
Primary Designation Director
Industry Trading
First Appointment 25 Oct 2012
Oldest Company Age 19 yrs
Largest company Kiran Pharmaceuticals Private Limited · ₹11.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 20122007₹11.4 Lakh (FY 2024)Active

Board colleagues of Madhu Singh

Directorship timeline

Open interactive timeline →
Kiran Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Madhu Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhu Singh

Madhu Singh currently holds 1 directorship: Kiran Pharmaceuticals Private Limited (Director, since 25 Oct 2012, revenue ₹11.4 Lakh (FY 2024)).

Madhu Singh was first appointed on 25 Oct 2012 as Director at Kiran Pharmaceuticals Private Limited.

The current boards of Madhu Singh's companies include Rohit Raj Singh (Kiran Pharmaceuticals Private Limited), Sidharth Raj Singh (Kiran Pharmaceuticals Private Limited), Sonal Singh (Kiran Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available